Property History
Broker Reported
Public Record
Activated On
Sold Price
Description
Marketing Description
Marketing Description Text
Investment Highlights
Remaining Term
Tenancy
Occupancy
Brokers
Lease Type
Sale Cap Rate
Sale Net Operating Income
Price/Sq Ft
Asking Price
Asking Cap Rate
Asking Price Per Square Foot
Days on Market
Brokerage(s)
Rent Bumps
Property Type
Property Type
Asking Details
Asking Cap Rate
Marketing Description
Stan Johnson Company is pleased to offer for sale to qualified investors a property that is 100% leased to Novanta (“Novanta”), a NASDAQ publicly listed company with a market capitalization of $2.3 billion (as of October 2018). The property is located in North Syracuse, New York and serves as the headquarters for Novanta’s wholly owned subsidiary: JADAK Technologies (“JADAK”).
Novanta was founded in 1968 and designs, manufactures and sells precision photonic and motion control components. Novanta is a leader in mission-critical technologies serving the medical and advanced industrial markets and offers its products to original equipment manufacturers (OEMs). Novanta has invested significantly in medical industry related M&A and has experienced tremendous financial growth. The company’s revenues have grown from $225 million in 2012 to just under $600 million in 2018, representing an 18% compound annual growth rate.
Investment Highlights
- Public Company with Investment Grade Quality Credit
- Strong Financial Growth
- Mission-Critical Facility
- Long-Term Lease
- Strong Market
- Excellent Location
Property Type
Property Type
Asking Details
Asking Cap Rate
Marketing Description
Stan Johnson Company is pleased to offer for sale to qualified investors a property that is 100% leased to Novanta Inc. (“Novanta”), a NASDAQ publicly listed company with a market capitalization of $2.3 billion (as of October 2018). The property is located in North Syracuse, New York and serves as the headquarters for Novanta’s wholly owned subsidiary: JADAK Technologies (“JADAK”). Novanta was founded in 1968 and designs, manufactures and sells precision photonic and motion control components. Novanta is a leader in mission-critical technologies serving the medical and advanced industrial markets and offers its products to original equipment manufacturers (OEMs). Novanta has invested significantly in medical industry related M&A and has experienced tremendous financial growth. The company’s revenues have grown from $225 million in 2012 to just under $600 million in 2018, representing an 18% compound annual growth rate.
Investment Highlights
- Public Company with Investment Grade Quality Credit
- Strong Financial Growth
- Mission-Critical Facility
- Long-Term Lease
- Strong Market
- Excellent Location
Loan History
Financial History
****** Data
Net Operating Income
Reporting Date
Revenue
Expenses
Mortgage Payment
Cash Flow
****** Data
Net Operating Income
Reporting Date
Tax History
Contact Information
These phone numbers and email addresses are checked against the litigator and TCPA lists. Report an error
Ownership Information
Property Details
There are no additional details for this property
Contacts
Map
Comparable Properties
Does any data look off? Help us improve Crexi by offering your feedback!









